Sangamo Therapeutics
SGMO
SGMO
118 hedge funds and large institutions have $241M invested in Sangamo Therapeutics in 2017 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 29 increasing their positions, 40 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
6% less funds holding
Funds holding: 126 → 118 (-8)
28% less repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 40
Holders
118
Holding in Top 10
1
Calls
$3.91M
Puts
$2.49M
Top Buyers
| 1 | +$29.2M | |
| 2 | +$23M | |
| 3 | +$4.42M | |
| 4 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$4.13M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$2.6M |
Top Sellers
| 1 | -$2.16M | |
| 2 | -$1.53M | |
| 3 | -$1.45M | |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$1.02M |
| 5 |
Renaissance Technologies
New York
|
-$982K |